Regulatory T cells and rheumatic diseases;Regulatorische T-Zellen und rheumatische Erkrankungen

Zeitschrift fur Rheumatologie

Volumn 74, Issue 1, 2015, Pages 26-32

  Humrich, J Y ^a   Kamradt, T ^b   Riemekasten, G ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Autoimmunity; Immunology; Immunotherapy; Pathogenesis; Tolerance

Indexed keywords

ARTICLE; AUTOIMMUNITY; PATHOGENESIS; REGULATORY T LYMPHOCYTE; RHEUMATIC DISEASE; AUTOIMMUNE DISEASE; BIOLOGICAL MODEL; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; PATHOLOGY;

AUTOIMMUNE DISEASES; HUMANS; IMMUNITY, INNATE; MODELS, IMMUNOLOGICAL; RHEUMATIC DISEASES; T-LYMPHOCYTES, REGULATORY;

EID: 84922691219     PISSN: 03401855     EISSN: 14351250     Source Type: Journal    
DOI: 10.1007/s00393-014-1446-4     Document Type: Article

References (29)

1. Cooles FA, Isaacs JD, Anderson AE (2013) Treg cells in rheumatoid arthritis: an update. Curr Rheumatol Rep 15:352
2. Cutolo M (2013) Further emergent evidence for the vitamin D endocrine system involvement in autoimmune rheumatic disease risk and prognosis. Ann Rheum Dis 72:473–475
3. Dieckmann D, Plottner H, Berchtold S et al (2001) Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med 193:1303–1310
4. Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4:330–336
5. Fontenot JD, Rasmussen JP, Gavin MA et al (2005) A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6:1142–1151
6. Gershon RK, Kondo K (1970) Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 18:723–737
7. Gomez-Martin D, Diaz-Zamudio M, Crispin JC et al (2009) Interleukin 2 and systemic lupus erythematosus: beyond the transcriptional regulatory net abnormalities. Autoimmun Rev 9:34–39
8. Green DR, Flood PM, Gershon RK (1983) Immunoregulatory T-cell pathways. Annu Rev Immunol 1:439–463
9. Huehn J, Polansky JK, Hamann A (2009) Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? Nat Rev Immunol 9:83–89
10. Humrich JY, Morbach H, Undeutsch R et al (2010) Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus. Proc Natl Acad Sci U S A 107:204–209
11. Kim JM, Rasmussen JP, Rudensky AY (2007) Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 8:191–197
12. Koreth J, Matsuoka K, Kim HT et al (2011) Interleukin-2 and regulatory T cells in graft-versus-host disease. N Engl J Med 365:2055–2066
13. Long SA, Buckner JH (2011) CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game. J Immunol 187:2061–2066
14. Malek TR, Castro I (2010) Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity 33:153–165
15. Michels-Van Amelsfort JM, Walter GJ, Taams LS (2011) CD4+CD25+ regulatory T cells in systemic sclerosis and other rheumatic diseases. Expert Rev Clin Immunol 7:499–514
16. Miyara M, Amoura Z, Parizot C et al (2005) Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 175:8392–8400
17. Miyara M, Gorochov G, Ehrenstein M et al (2011) Human FoxP3+ regulatory T cells in systemic autoimmune diseases. Autoimmun Rev 10:744–755
18. Nishizuka Y, Sakakura T (1969) Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 166:753–755
19. Saadoun D, Rosenzwajg M, Joly F et al (2011) Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N Engl J Med 365:2067–2077
20. Sadlack B, Lohler J, Schorle H et al (1995) Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur J Immunol 25:3053–3059
21. Sakaguchi S, Sakaguchi N, Asano M et al (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151–1164
22. Sakaguchi S, Vignali DA, Rudensky AY et al (2013) The plasticity and stability of regulatory T cells. Nat Rev Immunol 13:461–467
23. Sakaguchi S, Wing K, Miyara M (2007) Regulatory T cells – a brief history and perspective. Eur J Immunol 37(Suppl 1):S116–S123
24. Sakaguchi S, Yamaguchi T, Nomura T et al (2008) Regulatory T cells and immune tolerance. Cell 133:775–787
25. Setoguchi R, Hori S, Takahashi T et al (2005) Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 201:723–735
26. Shevach EM (2009) Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30:636–645
27. Suen JL, Li HT, Jong YJ et al (2009) Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus. Immunology 127:196–205
28. Venigalla RK, Tretter T, Krienke S et al (2008) Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus. Arthritis Rheum 58:2120–2130
29. Weigert O, von Spee C, Undeutsch R et al (2013) CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice. Arthritis Res Ther 15:R35